Iradimed Corp (IRMD): 3 Things That Stood Out From Q1 Report

Iradimed Corp (NASDAQ:IRMD) is one of the best micro and small cap stocks to buy according to Jim Simons’ Renaissance Technologies. The stock has returned nearly 80% over the past year, and analysts see more upside potential in it.

Iradimed Corp (IRMD): 3 Things That Stood Out From Q1 Report

Iradimed reported its Q1 2026 results on May 1, and the results marked a strong start to 2026. First, revenue rose 13% YoY to $22 million, and net income jumped 24% to $5.8 million, or $0.45 per share. The increase in profit was supported by a combination of continued revenue growth and disciplined expense management.

Second, Iradimed hit a significant milestone in Q1 with the commercial launch of its next-generation 3870 MRI-compatible IV infusion pump system. The management has noted strong interest and strong early order activity for this product and expects significant shipments to start in Q2.

Sales are expected to accelerate in the back half of 2026, with Q3 expected to be the first period to reflect the full impact of 3870 shipments. With the next-gen 3870 hitting the market, Iradimed CEO Roger Susi said they are focused on delivering innovative solutions and generating strong returns for investors.

Third, Iradimed anticipates Q2 revenue in the range of $20 million to $21 million. It expects GAAP EPS in the band of $0.40 to $0.44. For full-year 2026, the company is projecting revenue to come between $91.0 million and $96.0 million, with GAAP EPS forecast in the range of $1.90 to $2.05.

Iradimed Corp (NASDAQ:IRMD) is a specialty medical device company. It provides non-magnetic MRI-compatible equipment designed to be safer for use during MRI procedures. Its portfolio includes portable infusion pumps that support continuous medication delivery, ferromagnetic detection systems, and patient vital signs monitors.

While we acknowledge the risk and potential of IRMD as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than IRMD and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 7 Best Small Cap Agriculture Stocks to Buy Now and 8 Best Gold Stocks Under $5.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1